Navigation Links
ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
Date:1/23/2008

l 2002 by The American Red Cross and ProMetic Life Sciences Inc., and allows for the exchange of technology and knowledge between the two organizations. PRDT's main goal is to develop products and devices to remove and detect different pathogens from biological sources. This research augments work that ProMetic, the American Red Cross and PRDT's scientific founders have been conducting independently for many years.

Forward Looking Statements

This press release contains forward-looking statements about ProMetic's objectives, strategies and businesses that involve risks and uncertainties. These statements are "forward-looking" because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. Such risks and assumptions include, but are not limited to, ProMetic's ability to develop, manufacture, and successfully commercialize value-added pharmaceutical products, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of ProMetic to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. You will find a more detailed assessment of the risks that could cause actual events or results to materially differ from our current expectations on page 21 of ProMetic's Annual Information Form for the year ended December 31, 2006, under the heading "Risk Factors". As a result, we cannot guarantee that any forward-looking statement will materialize. We assume no obligation to update any forward-looking statement even if new information becomes available, as a result of future events or for any other reason, unless requi
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
2. Vapotherm(R) Announces Validation of U.S. Patent
3. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
4. Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
5. Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability
6. Amarin Provides Business Update and Announces Implementation of Reverse Stock Split
7. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
8. Peptimmune Announces First Close of Series D Private Financing
9. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
10. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
11. Vasogen Announces 2007 Year-End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... and Hershey, PA (PRWEB) December 19, 2014 ... BJCT), a leading developer and manufacturer of needle-free ... into an agreement with Immunomic Therapeutics, Inc. (“ITI”) ... needle-free injection device with its LAMP™ vaccine platform. ... option for an exclusive Worldwide license to the ...
(Date:12/19/2014)... EVANSTON, Ill. , Dec. 19, 2014 ... to develop novel drugs for diseases of the central ... Ph.D., president and chief executive officer, will present at ... Dr. Riedel,s presentation will take place at 3:00 p.m. ... St. Francis in San Francisco, Calif. ...
(Date:12/19/2014)... Mass. , Dec. 19, 2014 Decision ... market will grow at a 12 percent compound annual ... result of the aging population and the increasing adoption ... Latin America will also spur demand for ... of dental implant and periodontal treatments. Other ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 Today, ... locate its pilot production facility and future company ... and produce innovative new materials that safely and ... not only because of its historic, strong support ... efforts to attract leading edge, technology-based companies such ...
Breaking Biology Technology:Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4
... May 19, 2011 Ardea Biosciences, Inc. (Nasdaq: ... completed, multi-center, Phase 1, monotherapy, dose-escalation study of BAY ... an Oral Abstract Session at the 2011 American Society ... on Sunday, June 5, 2011. Presentation ...
... 19, 2011 Isis Pharmaceuticals, Inc. (NASDAQ: ... $5 million milestone payment from GlaxoSmithKline (GSK) related to ... ISIS-TTRRx.  ISIS-TTRRx is designed to treat transthyretin amyloidosis, a ... of peripheral nerve and/or heart tissues . ISIS-TTRRx ...
... YORK, May 19, 2011 Reportlinker.com ... report is available in its catalogue: ... (MEMs) Devices Industry ... report analyzes the worldwide markets for ...
Cached Biology Technology:Ardea Biosciences Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at 2011 American Society of Clinical Oncology Annual Meeting 2Ardea Biosciences Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at 2011 American Society of Clinical Oncology Annual Meeting 3Isis Initiates Phase 1 Study of ISIS-TTRRx and Earns $5 Million Milestone Payment From GlaxoSmithKline 2Isis Initiates Phase 1 Study of ISIS-TTRRx and Earns $5 Million Milestone Payment From GlaxoSmithKline 3Isis Initiates Phase 1 Study of ISIS-TTRRx and Earns $5 Million Milestone Payment From GlaxoSmithKline 4Global Micro-Electromechanical Systems (MEMs) Devices Industry 2Global Micro-Electromechanical Systems (MEMs) Devices Industry 3Global Micro-Electromechanical Systems (MEMs) Devices Industry 4Global Micro-Electromechanical Systems (MEMs) Devices Industry 5Global Micro-Electromechanical Systems (MEMs) Devices Industry 6Global Micro-Electromechanical Systems (MEMs) Devices Industry 7Global Micro-Electromechanical Systems (MEMs) Devices Industry 8Global Micro-Electromechanical Systems (MEMs) Devices Industry 9Global Micro-Electromechanical Systems (MEMs) Devices Industry 10Global Micro-Electromechanical Systems (MEMs) Devices Industry 11Global Micro-Electromechanical Systems (MEMs) Devices Industry 12Global Micro-Electromechanical Systems (MEMs) Devices Industry 13Global Micro-Electromechanical Systems (MEMs) Devices Industry 14Global Micro-Electromechanical Systems (MEMs) Devices Industry 15Global Micro-Electromechanical Systems (MEMs) Devices Industry 16Global Micro-Electromechanical Systems (MEMs) Devices Industry 17Global Micro-Electromechanical Systems (MEMs) Devices Industry 18Global Micro-Electromechanical Systems (MEMs) Devices Industry 19Global Micro-Electromechanical Systems (MEMs) Devices Industry 20Global Micro-Electromechanical Systems (MEMs) Devices Industry 21Global Micro-Electromechanical Systems (MEMs) Devices Industry 22Global Micro-Electromechanical Systems (MEMs) Devices Industry 23Global Micro-Electromechanical Systems (MEMs) Devices Industry 24
(Date:12/17/2014)... 15, 2014 Research and Markets ... the "Samsung Galaxy S5 - Home Button ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... sensing technology than the iPhone 5S, Samsung introduces ... its product. The Galaxy S5 home ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ... "Global Chemical Sensor Market 2015-2019" report to ... One major trend upcoming in ... sensors in biomedical applications. Chemical sensors help in ... diagnosis during surgical procedures. The Global Chemical Sensor ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... to their offering. One major ... of multimodal biometric systems. Multimodal biometric systems utilize ... verification and identification purposes. This helps to reduce ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... species in streams begins to occur at the initial stages ... USGS. The study found that streams are more sensitive to ... of waterways as fragile organisms, and yet that is exactly ... telling us," said USGS Director Marcia McNutt. "Streams are more ...
... This release is available in French . ... according to a review lead by Gabriel Shapiro of the ... Mother and Child Hospital. Women are at the highest risk ... a child may trigger a depressive episode in vulnerable women. ...
... at the National Institute of Standards and Technology (NIST) ... nanotubes (SWCNTs) may help protect DNA molecules from damage ... process in which a reactive chemical removes electrons from ... cells. More studies are needed to see if the ...
Cached Biology News:Streams show signs of degradation at earliest stages of urban development 2NIST study suggests carbon nanotubes may protect DNA from oxidation 2
This free-standing laminar flow hood provides a vertical flow of HEPA-filtered air to create a clean processing area. It includes a fluorescent light and motorized sliding shield. Options include wor...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: rack ...
... GX-1000 3-D Shaker , ,Product Information ... of the GyroTwister GX-1000 is extremely efficient, ... general mixing as well as staining gels, ... continuously adjustable across a broad range. A ...
...
Biology Products: